278 related articles for article (PubMed ID: 17725560)
41. Methods for Elucidating the Mechanism of Action of Proline-Rich and Other Non-lytic Antimicrobial Peptides.
Benincasa M; Runti G; Mardirossian M; Gennaro R; Scocchi M
Methods Mol Biol; 2017; 1548():283-295. PubMed ID: 28013512
[TBL] [Abstract][Full Text] [Related]
42. Functional interplay between the ATP binding cassette Msr(D) protein and the membrane facilitator superfamily Mef(E) transporter for macrolide resistance in Escherichia coli.
Nunez-Samudio V; Chesneau O
Res Microbiol; 2013 Apr; 164(3):226-35. PubMed ID: 23261969
[TBL] [Abstract][Full Text] [Related]
43. Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide.
Ghiselli R; Giacometti A; Cirioni O; Circo R; Mocchegiani F; Skerlavaj B; D'Amato G; Scalise G; Zanetti M; Saba V
Shock; 2003 Jun; 19(6):577-81. PubMed ID: 12785015
[TBL] [Abstract][Full Text] [Related]
44. Effect of size and N-terminal residue characteristics on bacterial cell penetration and antibacterial activity of the proline-rich peptide Bac7.
Guida F; Benincasa M; Zahariev S; Scocchi M; Berti F; Gennaro R; Tossi A
J Med Chem; 2015 Feb; 58(3):1195-204. PubMed ID: 25525837
[TBL] [Abstract][Full Text] [Related]
45. Influence of Substitutions in the Binding Motif of Proline-Rich Antimicrobial Peptide ARV-1502 on 70S Ribosome Binding and Antimicrobial Activity.
Brakel A; Krizsan A; Itzenga R; Kraus CN; Otvos L; Hoffmann R
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328571
[TBL] [Abstract][Full Text] [Related]
46. Identification of Api88 Binding Partners in Escherichia coli Using a Photoaffinity-Cross-Link Strategy and Label-Free Quantification.
Volke D; Krizsan A; Berthold N; Knappe D; Hoffmann R
J Proteome Res; 2015 Aug; 14(8):3274-83. PubMed ID: 26196380
[TBL] [Abstract][Full Text] [Related]
47. Cellular uptake of apidaecin 1b and related analogs in Gram-negative bacteria reveals novel antibacterial mechanism for proline-rich antimicrobial peptides.
Berthold N; Hoffmann R
Protein Pept Lett; 2014 Apr; 21(4):391-8. PubMed ID: 24164266
[TBL] [Abstract][Full Text] [Related]
48. Proline-rich antimicrobial peptides: converging to a non-lytic mechanism of action.
Scocchi M; Tossi A; Gennaro R
Cell Mol Life Sci; 2011 Jul; 68(13):2317-30. PubMed ID: 21594684
[TBL] [Abstract][Full Text] [Related]
49. Exploring the multi-drug resistance in Escherichia coli O157:H7 by gene interaction network: A systems biology approach.
Miryala SK; Ramaiah S
Genomics; 2019 Jul; 111(4):958-965. PubMed ID: 29908320
[TBL] [Abstract][Full Text] [Related]
50. Bacterial multi-solute transporters.
Slotboom DJ; Ettema TW; Nijland M; Thangaratnarajah C
FEBS Lett; 2020 Dec; 594(23):3898-3907. PubMed ID: 32810294
[TBL] [Abstract][Full Text] [Related]
51. Mechanism of action of puroindoline derived tryptophan-rich antimicrobial peptides.
Haney EF; Petersen AP; Lau CK; Jing W; Storey DG; Vogel HJ
Biochim Biophys Acta; 2013 Aug; 1828(8):1802-13. PubMed ID: 23562406
[TBL] [Abstract][Full Text] [Related]
52. Effect of distal sugar and interglycosidic linkage of disaccharides on the activity of proline rich antimicrobial glycopeptides.
Lele DS; Dwivedi R; Kumari S; Kaur KJ
J Pept Sci; 2015 Nov; 21(11):833-44. PubMed ID: 26424213
[TBL] [Abstract][Full Text] [Related]
53. Quorum sensing peptides mediating interspecies bacterial cell death as a novel class of antimicrobial agents.
Kumar S; Engelberg-Kulka H
Curr Opin Microbiol; 2014 Oct; 21():22-7. PubMed ID: 25244032
[TBL] [Abstract][Full Text] [Related]
54. iTRAQ-Based Quantitative Proteomic Analysis of the Antimicrobial Mechanism of Peptide F1 against Escherichia coli.
Miao J; Chen F; Duan S; Gao X; Liu G; Chen Y; Dixon W; Xiao H; Cao Y
J Agric Food Chem; 2015 Aug; 63(32):7190-7. PubMed ID: 26208148
[TBL] [Abstract][Full Text] [Related]
55. YojI of Escherichia coli functions as a microcin J25 efflux pump.
Delgado MA; Vincent PA; Farías RN; Salomón RA
J Bacteriol; 2005 May; 187(10):3465-70. PubMed ID: 15866933
[TBL] [Abstract][Full Text] [Related]
56. Novel histone-derived antimicrobial peptides use different antimicrobial mechanisms.
Pavia KE; Spinella SA; Elmore DE
Biochim Biophys Acta; 2012 Mar; 1818(3):869-76. PubMed ID: 22230351
[TBL] [Abstract][Full Text] [Related]
57. Bacterial resistance to antisense peptide phosphorodiamidate morpholino oligomers.
Puckett SE; Reese KA; Mitev GM; Mullen V; Johnson RC; Pomraning KR; Mellbye BL; Tilley LD; Iversen PL; Freitag M; Geller BL
Antimicrob Agents Chemother; 2012 Dec; 56(12):6147-53. PubMed ID: 22985881
[TBL] [Abstract][Full Text] [Related]
58. Selective antimicrobial activity and mode of action of adepantins, glycine-rich peptide antibiotics based on anuran antimicrobial peptide sequences.
Ilić N; Novković M; Guida F; Xhindoli D; Benincasa M; Tossi A; Juretić D
Biochim Biophys Acta; 2013 Mar; 1828(3):1004-12. PubMed ID: 23196344
[TBL] [Abstract][Full Text] [Related]
59. YehZYXW of Escherichia coli Is a Low-Affinity, Non-Osmoregulatory Betaine-Specific ABC Transporter.
Lang S; Cressatti M; Mendoza KE; Coumoundouros CN; Plater SM; Culham DE; Kimber MS; Wood JM
Biochemistry; 2015 Sep; 54(37):5735-47. PubMed ID: 26325238
[TBL] [Abstract][Full Text] [Related]
60. Novel macrolide-specific ABC-type efflux transporter in Escherichia coli.
Kobayashi N; Nishino K; Yamaguchi A
J Bacteriol; 2001 Oct; 183(19):5639-44. PubMed ID: 11544226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
